1. Role of CC Chemokines Subfamily in the Platinum Drugs Resistance Promotion in Cancer
   Maria E. Reyes et al, 2020, Front. Immunol. CrossRef
2. Single Cell Hydrodynamic Stretching and Microsieve Filtration Reveal Genetic, Phenotypic and Treatment-Related Links to Cellular Deformability
   Fenfang Li et al, 2020, Micromachines CrossRef
3. Is the C-C Motif Ligand 2–C-C Chemokine Receptor 2 Axis a Promising Target for Cancer Therapy and Diagnosis?
   Hiroaki Iwamoto et al, 2020, IJMS CrossRef
4. Co-Targeting PIM Kinase and PI3K/mTOR in NSCLC.
   Gillian Moore et al, 2021, Cancers (Basel) CrossRef
5. Roles of CCL2-CCR2 Axis in the Tumor Microenvironment
   Suguru Kadomoto et al, 2021, IJMS CrossRef
6. Surgical Trauma-Induced CCL2 Upregulation Mediates Lung Cancer Progression by Promoting Treg Recruitment in Mice and Patients
   Su Zhao et al, 2021, Cancer Investigation CrossRef
7. CC Chemokine Ligand-2: A Promising Target for Overcoming Anticancer Drug Resistance
   Zhenbo Shi et al, 2022, Cancers CrossRef
8. Updates in pharmacotherapy for non-small cell lung cancer: a focus on emerging tubulin inhibitors
   Simone Nardin et al, 2024, Expert Opinion on Pharmacotherapy CrossRef